🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study aimed to investigate the short-term efficacy and long-term progno...
Status
Completed
Location
The Third Affiliated Hospital Of Sun Yat-sen University
Start Date
2005-05
Trial ID
NCT00956891
This study aims to assess and compare the safety and effectiveness of Autol...
Status
Completed
Location
Cell Therapy Center, University of Jordan
Start Date
2017-08-15
Trial ID
NCT04288934
Treatments Being Tested
Busulfan (Bu) has been widely used for the treatment of neoplastic and non-...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT03492749
Treatments Being Tested
Children treated by bone marrow transplantation (BMT) experience bone toxic...
Status
Withdrawn
Location
St. Justine 's Hospital
Start Date
2016-12
Trial ID
NCT02677246
Treatments Being Tested
About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-07-01
Trial ID
NCT00712582
RATIONALE: A peripheral stem cell transplant or an umbilical cord blood tra...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2006-02
Trial ID
NCT00281879
Treatments Being Tested
The aim of this clinical trial is to evaluate the feasibility, safety and b...
Status
Terminated
Location
Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum
Start Date
2012-05
Trial ID
NCT01195480
Background: Blood cancers (such as leukemias or lymphomas) often do not re...
Status
Recruiting
Location
City of Hope
Start Date
2022-11-18
Trial ID
NCT05436418
The purpose of this study is to determine whether patients are able to part...
Status
Completed
Location
Penn State Cancer Institute
Start Date
2019-06-28
Trial ID
NCT03886909
Treatments Being Tested
This is a Phase II trial testing disease-specific myeloablative conditionin...
Status
Withdrawn
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2022-09
Trial ID
NCT04282174